Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir vs protease inhibitor-based therapy in HIV/HCV co-infected injecting drug users on methadone
2010-018326-39Phase 4Terminated
- Sponsor
- Department of Genito-Urinary Medicine and Infectious Diseases
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of raltegravir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Department of Genito-Urinary Medicine and Infectious Diseases. Started Jan 2010; status: terminated.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-018326-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018326-39.